Elisabetta Rovida

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Venues

International journal of molecular sciences

Cells

Oncogene

Cancers

Università degli Studi di Firenze

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Firenze Sep 01 2016

Italy

Assistant Professor

Università degli Studi di Firenze

Italy

Assistant Professor

Publications

Zoe Lombardi, Lucia Gardini, Anatolii V Kashchuk, Alessio Menconi, Matteo Lulli, Ignazia Tusa, Alessandro Tubita, Luisa Maresca, Barbara Stecca, Marco Capitanio, Elisabetta Rovida
Importin subunit beta-1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation. Molecular oncology (2024)
Ignazia Tusa, Alessio Menconi, Alessandro Tubita, Elisabetta Rovida
Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress. Cells 12 (8) (2023)
Isabelle Seidita, Ignazia Tusa, Matteo Prisinzano, Alessio Menconi, Francesca Cencetti, Silvia Vannuccini, Francesca Castiglione, Paola Bruni, Felice Petraglia, Caterina Bernacchioni, Elisabetta Rovida, Chiara Donati
Sphingosine 1-phosphate elicits a ROS-mediated proinflammatory response in human endometrial stromal cells via ERK5 activation. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (8) (2023)
Ignazia Tusa, Alessio Menconi, Alessandro Tubita, Elisabetta Rovida
Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress. Cells 12 (8) (2023)
Ignazia Tusa, Alessio Menconi, Alessandro Tubita, Elisabetta Rovida
Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress. Cells 12 (8) (2023)
Elisabetta Rovida, Ignazia Tusa
Targeting MAPK in Cancer 2.0. International journal of molecular sciences 23 (10) (2022)
Roberto Maglie, Carolina Vieira De Almeida, Maria Efenesia Baffa, Beatrice Bianchi, Marzia Caproni, Giovanni Di Zenzo, Xiaoguang Li, Yoshiaki Hirako, Takashi Hashimoto, Ignazia Tusa, Matteo Lulli, Elisabetta Rovida, Emiliano Antiga
Anti-β4 integrin autoantibodies in patients with mucous membrane pemphigoid: A retrospective analysis from a tertiary centre in Italy. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Ignazia Tusa, Giulia Cheloni, Martina Poteti, Angela Silvano, Alessandro Tubita, Zoe Lombardi, Antonella Gozzini, Roberto Caporale, Barbara Scappini, Persio Dello Sbarba, Elisabetta Rovida
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features. Targeted oncology 15 (5) (2021)
Martina Poteti, Giulio Menegazzi, Silvia Peppicelli, Ignazia Tusa, Giulia Cheloni, Angela Silvano, Caterina Mancini, Alessio Biagioni, Alessandro Tubita, Nathalie M Mazure, Matteo Lulli, Elisabetta Rovida, Persio Dello Sbarba
Glutamine Availability Controls BCR/Abl Protein Expression and Functional Phenotype of Chronic Myeloid Leukemia Cells Endowed with Stem/Progenitor Cell Potential. Cancers 13 (17) (2021)
Ignazia Tusa, Sinforosa Gagliardi, Alessandro Tubita, Silvia Pandolfi, Alessio Menconi, Matteo Lulli, Persio Dello Sbarba, Barbara Stecca, Elisabetta Rovida
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells. International journal of molecular sciences 22 (20) (2021)
Alessandro Tubita, Zoe Lombardi, Ignazia Tusa, Persio Dello Sbarba, Elisabetta Rovida
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy. International journal of molecular sciences 21 (3) (2020)
Barbara Stecca, Elisabetta Rovida
Impact of ERK5 on the Hallmarks of Cancer. International journal of molecular sciences 20 (6) (2019)
Ignazia Tusa, Sinforosa Gagliardi, Alessandro Tubita, Silvia Pandolfi, Carmelo Urso, Lorenzo Borgognoni, Jinhua Wang, Xianming Deng, Nathanael S Gray, Barbara Stecca, Elisabetta Rovida
ERK5 is activated by oncogenic BRAF and promotes melanoma growth. Oncogene 37 (19) (2018)
Giulia Cheloni, Michele Tanturli, Ignazia Tusa, Ngoc Ho DeSouza, Yi Shan, Antonella Gozzini, Fréderic Mazurier, Elisabetta Rovida, Shaoguang Li, Persio Dello Sbarba
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. Blood 130 (5) (2017)

Elisabetta Rovida.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Elisabetta Rovida